Euro
USD
British Pound
NULL
Product Description
Rivastigmine is a cholinesterase (ChE) inhibitor that inhibits butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) with IC₅₀ values of 0.037 μM and 4.15 μM respectively. It is used for the treatment of dementia in Alzheimer's disease and Parkinson's disease.
Rivastigmine is a cholinesterase (ChE) inhibitor that inhibits butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) with IC₅₀ values of 0.037 μM and 4.15 μM respectively. It is used for the treatment of dementia in Alzheimer's disease and Parkinson's disease.
Biovision | B3093 | Rivastigmine tartrate DataSheet
Alternate Name/Synonyms: (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate; Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1); SDZ-ENA 713; ENA 713; Exelon
Appearance: White solid
Formulation:
CAS Number: 129101-54-8
Structure Available?: TRUE
Peptide sequence:
Salt Form: TRUE
Molecular Formula: C₁₈H₂₈N₂O₈
Molecular Weight: 400.42
Cell-Permeable?: True
Purity: ≥ 95%
Solubilities: ~16 mg/ml in DMSO and ethanol, ~10 mg/ml in PBS, pH 7.2, ~25 mg/ml in DMF
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An inhibitor of butyrylcholinesterase and acetylcholinesterase
MDL Number: MFCD03700731
PubChem CID: 6918078
SMILES: CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O
InChi: InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1
InChi Key: GWHQHAUAXRMMOT-MBANBULQSA-N
